Neurology

  • New guideline: Address GTCS frequency to reduce SUDEP risk

    on April 24th, 2017
    AT AAN 2017 BOSTON (FRONTLINE MEDICAL NEWS) – Generalized tonic-clonic seizures (GTCS) are a major risk factor for sudden unexpected death in epilepsy (SUDEP), which underscores the importance of advising people with epilepsy about controlling such seizures, according to a new practice guideline f[...]
  • After the epidemic, Ebola’s destructive power still haunts survivors

    on April 24th, 2017
    AT ECCMID 2017 VIENNA (FRONTLINE MEDICAL NEWS) – The Ebola crisis may be over in Sierra Leone, but the suffering is not. The last patient from the epidemic was discharged in February 2016, but 78% of survivors now appear to have one or more sequelae of the infection. Some problems are mild, but so[...]
  • Truncal vagotomy might help delay Parkinson’s disease

    on April 24th, 2017
    FROM NEUROLOGY Patients who were followed for more than 5 years after truncal vagotomy had about a 40% lower risk of being diagnosed with Parkinson’s disease, compared with matched population controls, according to the results of a cohort registry study. Selective vagotomy did not decrease the ris[...]
  • Parkinson’s patients’ quality of life improves after deep brain stimulation

    on April 24th, 2017
    AT AAN 2017 BOSTON (FRONTLINE MEDICAL NEWS)– Early results from an industry-funded registry of Parkinson’s disease patients who underwent deep brain stimulation (DBS) reveal that their quality-of-life scores grew by 22% at 6 months. Patients, their caregivers, and their clinicians all overwhelmi[...]
  • Prenotification, unequivocal stroke promote ultra-fast door-to-needle time

    on April 24th, 2017
    AT AAN 2017 BOSTON (FRONTLINE MEDICAL NEWS) – Ultra-fast door-to-needle times of 10 minutes or less for intravenous acute ischemic stroke thrombolysis can be safely achieved in carefully selected cases, according to a review of cases at an Austrian teaching hospital. Raffi Topakian, MD , and his c[...]
  • Sepsis survivors may have high risk for seizures

    on April 24th, 2017
    AT AAN 2017 BOSTON (FRONTLINE MEDICAL NEWS) – Survivors of sepsis face a significantly increased risk of seizures following an index hospitalization, regardless of any previous history of seizures or seizures occurring during hospitalization, according to findings from a retrospective, population-[...]
  • High early stroke risk for adult congenital heart disease

    on April 21st, 2017
    AT ACC 17 WASHINGTON (FRONTLINE MEDICAL NEWS) – Adults with congenital heart disease are at fourfold greater risk of experiencing an ischemic stroke by age 60 than is the general population, Mette Glavind reported at the annual meeting of the American College of Cardiology. She presented a populat[...]
  • DTC genetic health risk tests: Beware

    on April 21st, 2017
    The Food and Drug Administration recently authorized 23andMe to provide consumers with results of germline DNA sequence variants associated with risk for 10 health conditions, among them hereditary hemochromatosis, alpha-1 antitrypsin deficiency, celiac disease, Alzheimer’s disease, and Parkinson[...]
  • FDA approves new treatment for episodic cluster headaches in adults

    on April 19th, 2017
    The Food and Drug Administration announced April 18 the approval of the gammaCore device to treat pain associated with episodic cluster headache in adult patients. The agency based its approval of the noninvasive vagus nerve stimulator device on subgroup analyses of episodic cluster headache patient[...]
  • Waldenström macroglobulinemia panel advises on IgM paraproteinemic neuropathies

    on April 19th, 2017
    FROM THE BRITISH JOURNAL OF HAEMATOLOGY With optimal approaches still evolving for the diagnosis and management of peripheral neuropathies associated with Waldenström macroglobulinemia and other IgM paraproteinemias, new consensus recommendations from a multidisciplinary panel were recently publish[...]
  • FDA approves Ingrezza for tardive dyskinesia in adults

    on April 12th, 2017
    The Food and Drug Administration has approved valbenazine capsules for the treatment of tardive dyskinesia in adults. The approval, announced April 11, came after a 6-week, placebo-controlled trial of 234 participants that compared valbenazine to placebo. At the end of the trial, those who took valb[...]
  • Lifetime headache, suicide attempts may be linked in older patients

    on April 7th, 2017
    FROM EUROPEAN PSYCHIATRY Lifetime headaches appear to be closely associated with lifetime suicide attempts among older patients, a study of 1,965 community-dwelling participants aged 65 years and older suggests. The results hold “even after adjusting for various confounding variables such as depre[...]
  • Evidence for medical marijuana largely up in smoke

    on April 7th, 2017
    EXPERT ANALYSIS AT ACP INTERNAL MEDICINE SAN DIEGO (FRONTLINE MEDICAL NEWS) – Despite the popularity of medical marijuana, robust evidence for its use is limited or nonexistent for most medical conditions. “This is a tough subject to study,” Ellie Grossman, MD, said at the annual meeting of th[...]
Back to top